Literature DB >> 12939403

Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo.

Esteban Mazzoni1, Alejandro Adam, Elisa Bal de Kier Joffe, Julio A Aguirre-Ghiso.   

Abstract

We have investigated the role of a classical isoform of protein kinase C (PKCgamma) in promoting immortalized mammary cell tumorigenesis in vivo and the contribution of proteases and adhesion molecules to this process. We hypothesized that overexpression of PKCgamma in immortalized mammary epithelial cells may initiate, by activating the mitogenic ERK pathway, early changes in proteases, adhesion molecules, and markers of an epithelium-to-mesenchyme transition that may contribute to in vivo tumorigenesis. Here we show that compared to vector-transfected cells, immortalized murine mammary epithelial cells (NMuMG) overexpressing PKCgamma have stronger activation of (approximately 5-fold) ERK1/2 MAPKs, which results in a similar increase in cyclin D1. In addition, PKCgamma-expressing cells showed increased levels of vimentin, fibronectin (FN), beta1-integrins, enhanced adhesion to fibronectin, and its organization into fibrils. Concomitantly, PKCgamma induced a dramatic down-regulation of E-cadherin protein levels and its localization to cell-cell junctions. NMuMG cells expressing PKCgamma became resistant to death by anoikis and formed colonies in soft agar. This effect was dependent on ERK activation, because Mek1/2 inhibition with PD98059 abrogated anchorage-independent growth. Most importantly, unlike control NMuMG cells, PKCgamma-transfected cells inoculated s.c. into nude mice displayed tumorigenic and invasive capacity and were able to spontaneously metastasize. This behavior correlated with increased production of uPA and MMPs-9/-2 induced by PKCgamma. These results suggest that PKCgamma overexpression in immortalized mammary epithelial cells may generate, through an increase in ERK, signaling changes in the expression of genes associated with an epithelium-to-mesenchyme transition that may be sufficient to favor tumor growth in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939403

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  11 in total

1.  Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study.

Authors:  Huading Lu; Lei Zhu; Liyi Lian; Mingwei Chen; Dehai Shi; Kun Wang
Journal:  Tumour Biol       Date:  2015-02-09

2.  Comparative Analysis of microRNAs that Stratify in vitro Mammary stem and Progenitor Activity Reveals Functionality of Human miR-92b-3p.

Authors:  James L Miller; Matt Kanke; Gat Rauner; Kimaya M Bakhle; Praveen Sethupathy; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-10-03       Impact factor: 2.698

3.  p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin.

Authors:  Valerie Kedinger; Laurent Sansregret; Ryoko Harada; Charles Vadnais; Chantal Cadieux; Kelly Fathers; Morag Park; Alain Nepveu
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

4.  CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.

Authors:  Wei Bin Fang; Iman Jokar; An Zou; Diana Lambert; Prasanthi Dendukuri; Nikki Cheng
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

5.  Protein kinase C delta inhibits the production of proteolytic enzymes in murine mammary cells.

Authors:  Valeria C Grossoni; Karina B Falbo; Laura V Mauro; Martín A Krasnapolski; Marcelo G Kazanietz; Elisa D Bal De Kier Joffé; Alejandro J Urtreger
Journal:  Clin Exp Metastasis       Date:  2007-07-25       Impact factor: 5.150

6.  Deregulated Aurora-B induced tetraploidy promotes tumorigenesis.

Authors:  Hao G Nguyen; Maria Makitalo; Dan Yang; Dharmaraj Chinnappan; Cynthia St Hilaire; Katya Ravid
Journal:  FASEB J       Date:  2009-03-30       Impact factor: 5.191

7.  Single-nucleotide polymorphisms of the PRKCG gene and osteosarcoma susceptibility.

Authors:  Ying Zhang; Xu Hu; Hong-Kai Wang; Wei-Wei Shen; Tong-Quan Liao; Pei Chen; Tong-Wei Chu
Journal:  Tumour Biol       Date:  2014-09-25

Review 8.  Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling.

Authors:  Catríona M Dowling; Patrick A Kiely
Journal:  Cancers (Basel)       Date:  2015-07-15       Impact factor: 6.639

9.  Protein kinase C: an attractive target for cancer therapy.

Authors:  Barbara Marengo; Chiara De Ciucis; Roberta Ricciarelli; Maria A Pronzato; Umberto M Marinari; Cinzia Domenicotti
Journal:  Cancers (Basel)       Date:  2011-02-01       Impact factor: 6.639

10.  Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.

Authors:  Pau Creixell; Erwin M Schoof; Craig D Simpson; James Longden; Chad J Miller; Hua Jane Lou; Lara Perryman; Thomas R Cox; Nevena Zivanovic; Antonio Palmeri; Agata Wesolowska-Andersen; Manuela Helmer-Citterich; Jesper Ferkinghoff-Borg; Hiroaki Itamochi; Bernd Bodenmiller; Janine T Erler; Benjamin E Turk; Rune Linding
Journal:  Cell       Date:  2015-09-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.